Clinical Trials in New York

Showing 5501-5520 of 22,668 trials

A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma

NCT06057935

The purpose of this study is to find out whether intraperitoneal or intravenous chemotherapy given after cytoreductive surgery and HIPEC are effective treatments for people with malignant peritoneal mesothelioma. Outcomes will be compared by observing intraperitoneal versus intravenous treatments to analyze if one is better than the other.

Malignant Peritoneal MesotheliomaPeritoneal MesotheliomaMesothelioma+2 more

Memorial Sloan Kettering Cancer Center64 participantsStarted Sep 2023

Chicago, Illinois, United States • Ann Arbor, Michigan, United States • St Louis, Missouri, United States +10 more locations

COMPLETEDPhase 1/2< 1 mile

Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer

NCT04381832

This is a Phase 1b/2, open-label, multicenter platform trial to evaluate the antitumor activity and safety of etrumadenant (AB928)-based combination therapy in participants with metastatic castrate resistant prostate cancer (mCRPC).

Prostatic Neoplasms, Castration-ResistantAndrogen-Resistant Prostatic NeoplasmsCastration Resistant Prostatic Neoplasms+1 more

Arcus Biosciences, Inc.173 participantsStarted Jul 2020

Cerritos, California, United States • Encino, California, United States • Orange, California, United States +16 more locations

A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma

Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer

Find Trials by Condition in New York

Patient Controlled Epidural Analgesia Versus Intravenous Patient Controlled Analgesia for Post-Operative Pain Control in Patients Undergoing Elective Liver Resection

Evaluating the Combination of Everolimus and Sorafenib in the Treatment of Thyroid Cancer

Self-Management and Glycemic Control in Adult Haitian Immigrants With Type 2 Diabetes

Study of Ibrutinib Combined With Venetoclax in Subjects With Mantle Cell Lymphoma (MCL)

EXOMIND (BTL-699-2) for Improvement of Mental Well-being

Metastatic Spinal Bone Marrow Response to Radiation Therapy Using T1 Weighted Dynamic Contrast-Enhanced Perfusion

Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies

HER2 and LA/mUC: A Multi-country Chart Review Cohort Study

Study of SubQ Dara With Dose-Attenuated Bortezomib, Lenalidomide, Dexamethasone in Elderly NDMM

OPT-302 With Ranibizumab in Neovascular Age-related Macular Degeneration (nAMD)

A Study of BMS-986466 With Adagrasib With or Without Cetuximab in Participants With Kirsten Rat Sarcoma Virus Glycine 12 to Cysteine (KRAS G12C)-Mutant Solid Tumors

A Clinical Study on the Effects of a Dietary Supplement on Stress, Anxiety, Mood and Sleep in a Pediatric Population

A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis

Clinical Evaluation of Use of Prismocitrate 18 in Patients Undergoing Acute Continuous Renal Replacement Therapy (CRRT)

A Study of Atezolizumab Plus Cobimetinib and Vemurafenib Versus Placebo Plus Cobimetinib and Vemurafenib in Previously Untreated BRAFv600 Mutation-Positive Patients With Metastatic or Unresectable Locally Advanced Melanoma

IMPENDIA- PEN VS Dianeal Only Improved Metabolic Control In Diabetic CAPD and APD Patients

Treatment and Duration Effect of Pentosan Polysulfate Sodium (PPS) in Participants With Knee Osteoarthritis Pain

Temporally Interfering Electric Field Stimulation in the Treatment of Epilepsy